WT1 and breast cancer: These results favor a strong correlation between WT1 and miR-193a, indicating that restoration of miR-193a expression may be a promising strategy for breast cancer clinical therapies and that WT1 could be a novel biomarker of breast cancer prognosis and diagnosis, and a potential molecular therapeutic target.